89 results
8-K
EX-10.1
HBIO
Harvard Bioscience Inc.
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
. Executive shall be entitled to receive prompt reimbursement for all reasonable expenses incurred by Executive in performing services hereunder during
S-8
HBIO
Harvard Bioscience Inc.
8 Jun 22
Registration of securities for employees
4:41pm
and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act.
The foregoing summaries are qualified
S-8
HBIO
Harvard Bioscience Inc.
19 May 21
Registration of securities for employees
5:07pm
and the indemnification agreements may be sufficiently broad to permit indemnification of the Registrant’s officers and directors for liabilities, including reimbursement
8-K
EX-10.1
zh2v44cvbqzu01v7
19 May 21
Departure of Directors or Certain Officers
4:20pm
8-K
EX-10.1
01t69at5fh7dv lpoy
23 Dec 20
Harvard Bioscience Announces New Credit Facility
5:15pm
8-K
EX-10.2
wko4g
23 Dec 20
Harvard Bioscience Announces New Credit Facility
5:15pm
8-K
EX-10.3
iar vtsl6uoug
23 Dec 20
Harvard Bioscience Announces New Credit Facility
5:15pm
S-8
4x8zz9tfu ud7
6 Nov 20
Registration of securities for employees
5:00pm
8-K
EX-10.1
h2775
1 Nov 19
Harvard Bioscience Announces Executive Appointment
6:55am
8-K
EX-10.1
jhjar
19 Jul 19
Harvard Bioscience Names Michael Rossi Chief Financial Officer
4:50pm
8-K
EX-10.2
t205qze amhfc66
8 Jul 19
Departure of Directors or Certain Officers
8:05am
8-K
EX-10.1
g1kx isudkp
8 Jul 19
Departure of Directors or Certain Officers
8:05am
8-K
EX-10.1
yw46ukt1541tcxa
7 Nov 18
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
03ifm svnqrfh
22 Oct 18
Harvard Bioscience Names Kam Unninayar as Chief Financial Officer
5:00pm